Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > LABS commercialization wheels are now in full motion for

<< Previous

Bullboard Posts

Next >>

Comment by firemonkeyon May 03, 2024 5:16pm

126 Views

Post# 36022578

RE:RE:RE:RE:RE:LABS commercialization wheels are now in full motion for

5,000 shares at 8 cents did trade from Anonymous to Anonymous at 15:58:26 today. The 'official' $0.085 close was based on the last trade on the main TSX exchange, registered at 15:40:24.

Merrill Lynch bought $54,500 shares at 15:53:56 from other exchanges, in between the above two trades.

While the main TSX exchange only transacted 77,416 shares, the total volume traded at all exchanges amounted to 415,232 shares today.

If Q1 results would be released on or around May 15, there could be an announcement about that later next week. Indeed, next week's trading would be interesting ...

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023